PM360 2018 Innovative Product Access Express from Health Strategies Group, an EVERSANA company

Access Express

Health Strategies Group, an EVERSANA company

Rod Cavin, General Manager
info@healthstrategies.com 

Sometimes you need answers—fast. But fast shouldn’t mean you need to compromise on quality. Access Express is a self-service custom research tool for biopharmaceutical market researchers that leverages Health Strategies Group’s robust panel of providers and payers to provide answers to your questions in one week’s time.

Simply log on to an easy-to-use portal, select your target respondent roles, set your sample size preferences, and submit 5-10 questions. The entire research process—including survey programming—will be managed by Health Strategies Group’s experienced in-house research team. And the results will be available in six business days.

Access Express can provide quick, credible answers to time-sensitive questions, including the ability to:

  • Gather information you need for planning.
  • Answer questions from senior management.
  • Gain quick market reactions.
  • Monitor the effectiveness of your programs and tactics.
  • Assess the real-time impact of changes in formulary and contracts.

Access Express reduces the time for projects from 13 weeks to one week, creating a quick and cost-effective alternative for clients. Health Strategies Group recently completed 50 projects across a broad spectrum of needs, including business development, message testing, copay receptivity, and drug packaging receptivity.

Ads

You May Also Like

2017 Pharma Choice Gold Unbranded

Biosector 2 Sunovion Pharmaceuticals Inc. Be Vocal: Speak Up for Mental Health Be Vocal: ...

2017 Pharma Choice Bronze DTC/DTP

Dudnyk Shire Firazyr “Mantra” Patient and physician insights uncovered an opportunity to encourage patients ...

PM360 2019 Innovative Product TRINITY Forecasting Platform from TRINITY

TRINITY Forecasting Platform TRINITY Kevin Chithran, Principal kchithran@trinitylifesciences.com   Steve Fleming, Partner sfleming@trinitylifesciences.com    ...